E-Paper | June 14, 2026

Malaysia gives conditional approval for use of Ronapreve Covid-19 treatment

Published December 14, 2021
comments
Whatsapp Channel
Add Dawn as a trusted source
Google Preferred Source

Malaysia's health ministry says it has given conditional approval for the use of the single-dose antibody cocktail Ronapreve, developed by Regeneron and Roche to treat Covid-19, Reuters reports.

It has also approved a request from Merck & Co for a clinical trial import licence for its Covid-19 pill Molnupiravir, to be used as part of studies being conducted in Malaysia, the ministry said in a statement.

Our readers are at the heart of everything we do.
Do you have a thought to share or a way we can improve? We’d love to hear it. Reach out to us at feedback@dawn.com.
Live Coronavirus

Read more

Most Popular

01
02
03
04
05
06
07
08
09

Latest Stories

Opinion

Editorial

Budget presser
Updated 14 Jun, 2026

Budget presser

If the FBR falters, the government will find itself in hot water sooner rather than later.
Muharram precautions
14 Jun, 2026

Muharram precautions

WITH Muharram due to start next week, the authorities have already begun annual exercises to ensure that the ...
Blood bequests
14 Jun, 2026

Blood bequests

WORLD Blood Donor Day offers a moment of “gratitude, advocacy and renewed commitment” for thalassaemia patients...
Sustainable path?
Updated 13 Jun, 2026

Sustainable path?

The FY27 budget is the first clear signal that the government is ready to transition from stabilisation to growth.
Prioritising education
13 Jun, 2026

Prioritising education

THOUGH the improvement in the country’s literacy rate may be slight, as highlighted by the Economic Survey, it ...
Poverty’s rise
13 Jun, 2026

Poverty’s rise

AS attention turns to the government’s plans for the coming fiscal year, one set of figures deserves particular...
Dawn News English Podcasts
Subscribe